Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application

Patients with COVID-19 and metabolic-dysfunction associated fatty liver disease (MAFLD) appear to be at higher risk for severe manifestations, especially in the youngest decades. Our aim was to examine whether patients with MAFLD and/or with increased liver fibrosis scores (FIB-4) are at risk for se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoncapè, Mirko, Carlin, Michele, Bicego, Manuele, Simonetti, Andrea, Ceruti, Vittoria, Mantovani, Anna, Inglese, Francesco, Zamboni, Giulia, Sartorio, Andrea, Minuz, Pietro, Romano, Simone, Crisafulli, Ernesto, Sacerdoti, David, Fava, Cristiano, Dalbeni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
EM - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238243/
https://www.ncbi.nlm.nih.gov/pubmed/37268769
http://dx.doi.org/10.1007/s11739-023-03316-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238243/
https://www.ncbi.nlm.nih.gov/pubmed/37268769
http://dx.doi.org/10.1007/s11739-023-03316-6

Ejemplares similares